ATE188484T1 - Immunologisch mit hla homologe hiv protein epitope - Google Patents

Immunologisch mit hla homologe hiv protein epitope

Info

Publication number
ATE188484T1
ATE188484T1 AT93910325T AT93910325T ATE188484T1 AT E188484 T1 ATE188484 T1 AT E188484T1 AT 93910325 T AT93910325 T AT 93910325T AT 93910325 T AT93910325 T AT 93910325T AT E188484 T1 ATE188484 T1 AT E188484T1
Authority
AT
Austria
Prior art keywords
immunologically
hla
homologue
hiv protein
protein epitopes
Prior art date
Application number
AT93910325T
Other languages
English (en)
Inventor
Alberto Beretta
Original Assignee
San Raffaele Centro Fond
Fond Mondiale Rech & Prev Sida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by San Raffaele Centro Fond, Fond Mondiale Rech & Prev Sida filed Critical San Raffaele Centro Fond
Application granted granted Critical
Publication of ATE188484T1 publication Critical patent/ATE188484T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT93910325T 1992-05-11 1993-05-10 Immunologisch mit hla homologe hiv protein epitope ATE188484T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM920350A IT1254360B (it) 1992-05-11 1992-05-11 Epitopi immunologicamente omologhi di hla e proteine del virus hiv.
PCT/IT1993/000049 WO1993023427A1 (en) 1992-05-11 1993-05-10 Hiv protein epitopes immunologically homologous to hla

Publications (1)

Publication Number Publication Date
ATE188484T1 true ATE188484T1 (de) 2000-01-15

Family

ID=11400995

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93910325T ATE188484T1 (de) 1992-05-11 1993-05-10 Immunologisch mit hla homologe hiv protein epitope

Country Status (7)

Country Link
US (2) US6042831A (de)
EP (1) EP0641357B1 (de)
AT (1) ATE188484T1 (de)
CA (1) CA2135630C (de)
DE (1) DE69327529T2 (de)
IT (1) IT1254360B (de)
WO (1) WO1993023427A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254360B (it) * 1992-05-11 1995-09-14 San Romanello Centro Fond Epitopi immunologicamente omologhi di hla e proteine del virus hiv.
IT1264078B1 (it) * 1993-09-10 1996-09-10 San Romanello Centro Fond Uso di anticorpi anti-molecole hla classe i libere da beta-2 microglobulina per saggi di evidenziazione dell'esposizione al virus
CN1339320A (zh) * 2000-08-18 2002-03-13 清华大学 一种艾滋病疫苗及其制备方法与应用
US7923209B2 (en) 2003-03-14 2011-04-12 Anergis, S.A. Allergen peptide fragments and use thereof
WO2011119920A2 (en) 2010-03-25 2011-09-29 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
SMT201800284T1 (it) 2011-06-10 2018-07-17 Univ Oregon Health & Science Glicoproteine cmv e vettori ricombinanti
EP2568289A3 (de) 2011-09-12 2013-04-03 International AIDS Vaccine Initiative Immunselektion von rekombinantem vesikulärem Stomatitisvirus mit Expression von HIV-1-Proteinen durch Breitbandneutralisierungs-Antikörper
EP2586461A1 (de) 2011-10-27 2013-05-01 Christopher L. Parks Von einem eingehüllten Virus abgeleitete Virenpartikel
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
EP2848937A1 (de) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Verfahren zur Identifizierung neuartiger HIV-1-Immunogene
EP2873423B1 (de) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
WO2017152144A1 (en) * 2016-03-03 2017-09-08 Duke University Swarm immunization with envelopes from ch505

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4943628A (en) * 1988-06-13 1990-07-24 Ortho Pharmaceutical Corporation HIV peptide-inducted T cell stimulation
AU641814B2 (en) * 1990-09-25 1993-09-30 Peptech (Uk) Limited Aids therapy and vaccine
AU650911B2 (en) * 1990-09-27 1994-07-07 Syntello Vaccine Development Kb Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
IT1254360B (it) * 1992-05-11 1995-09-14 San Romanello Centro Fond Epitopi immunologicamente omologhi di hla e proteine del virus hiv.

Also Published As

Publication number Publication date
ITRM920350A1 (it) 1993-11-11
DE69327529T2 (de) 2000-08-10
IT1254360B (it) 1995-09-14
DE69327529D1 (de) 2000-02-10
US6042831A (en) 2000-03-28
EP0641357B1 (de) 2000-01-05
CA2135630A1 (en) 1993-11-25
US20020081566A1 (en) 2002-06-27
WO1993023427A1 (en) 1993-11-25
EP0641357A1 (de) 1995-03-08
ITRM920350A0 (it) 1992-05-11
CA2135630C (en) 2005-03-22

Similar Documents

Publication Publication Date Title
MY103182A (en) Vaccines against acquired immune deficiency syndrome.
DE69327529D1 (de) Immunologisch mit HLA homologe HIV Protein Epitope
ATE295895T1 (de) Genetischer impfstoff gegen den immunschwäche virus
DK0724432T3 (da) Fremgangsmåder og præparater til mikroindkapsling af antigener til brug som vacciner
EA199700272A1 (ru) Вакцины, содержащие сапонин и стерин
ATE233814T1 (de) Humaner neutralisierender monoklonaler antikörper gegen den die immunschwäche beim menschen hervorringenden virus
DK0527760T3 (da) Fremgangsmåder og præparater til vaccination mod HIV
ES2194836T3 (es) Peptidos para su uso en vacunacion e induccion de anticuerpos neutralizantes contra el virus de la inmunodeficiencia humana.
IT1197431B (it) Antigene anti-malarico, procedimento per la sua preparazione e vaccino che lo contiene
NO870476L (no) Fremgangsmaate for fremstilling av kryss-beskyttende humane monoklonale antistoffpreparater.
DK163062C (da) Antigen, immunogen, proteinholdig vaccine imod coccidiose
DK337479A (da) Fremgangsmaade til at modificere de antigeniske egenskaber hoset quercitindel-holdigt graespollen-antigen eller fragment deraf
HU9300009D0 (en) Glycoprotein vaccine named ehv-4
ATE72400T1 (de) Kreuzreaktive und schuetzende epitope von circumsporozoit-proteinen.
NO175846C (no) Fremgangsmåte for å oppnå et immunogen
DK102589D0 (da) Antigen, der genkendes af mca 16-88
DK46988A (da) Fremgangsmaade til fremstilling af katteleukaemivirusantigener og anvendelsen heraf
DE69119591D1 (de) Das von mca-28a32 erkannte antigen
DE69433057D1 (de) Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов